The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Patients with ankylosing spondylitis were found to be at an elevated risk of developing aortic valve regurgitation.
All-cause mortality and stroke are comparable at 30 days and one year after TAVR among patients with bicuspid and tricuspid valve stenosis.
The ACC published a focused update of the 2017 expert consensus decision pathway on the management of mitral regurgitation.
High CRP and low HDL-C levels at baseline were found to predict all-cause mortality in elderly patients who underwent TAVI.
The N-terminal pro–B-type natriuretic peptide ratio may improve prognosis in elderly patients with moderate to severe valvular heart disease.
The TriClip device may be safe and effective for lowering tricuspid regurgitation by 1 grade or more.
Atrial fibrillation, left ventricular ejection fraction (LVEF), abnormal right ventricular function, and ventricular hypertrophy were found to be associated with a greater risk for aortic valve replacement (AVR), death, or hospitalization for heart failure in patients with moderate aortic stenosis, according to a study published in The American Journal of Cardiology. In this retrospective single-center study,…
Investigators examined whether pretreatment low-density lipoprotein cholesterol levels and aortic stenosis severity affect lipid-lowering therapy to decrease aortic valve replacement.
Fluoroquinolone antibiotic exposure was linked to an increased risk of developing left-sided valvular regurgitation.